Concepedia

VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer

Reija Valtola, Petri Salvén, Päivi Heikkilä, Jussi Taipale, Heikki Joensuu, Marko Rehn, Taina Pihlajaniemi, Herbert A. Weich, Robert M. deWaal, Kari Alitalo

American Journal Of Pathology · 1999 · 545 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Cancer: Principles and Practice of Oncology.

Annals of Internal Medicine · 1991 · 8.5K citations

, , +10

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

K. Jin Kim, Bing Li, Jane Winer et al. · Nature · 1993 · 3.6K citations

, , +14

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

Noel Weidner, J Folkman, F. Pozza et al. · JNCI Journal of the National Cancer Institute · 1992 · 1.8K citations

, , +14

A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases.

Vladimir Joukov, Katri Pajusola, Arja Kaipainen et al. · The EMBO Journal · 1996 · 1.7K citations · Full text

, , +11

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

Arja Kaipainen, Jaana Korhonen, Tuija Mustonen et al. · Proceedings of the National Academy of Sciences · 1995 · 1.4K citations

, , +13